Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
News
Sports
TV & Film
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/af/62/cf/af62cf80-06ea-b9ca-c9af-6f2e30faaea8/mza_17495152926041384024.jpg/600x600bb.jpg
Cancer News Review – Johns Hopkins Medicine Podcasts
Johns Hopkins Medicine
37 episodes
1 month ago
Show more...
Medicine
Health & Fitness
RSS
All content for Cancer News Review – Johns Hopkins Medicine Podcasts is the property of Johns Hopkins Medicine and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Show more...
Medicine
Health & Fitness
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/af/62/cf/af62cf80-06ea-b9ca-c9af-6f2e30faaea8/mza_17495152926041384024.jpg/600x600bb.jpg
October 10, 2016 – Cancer News Review
Cancer News Review – Johns Hopkins Medicine Podcasts
8 minutes 36 seconds
8 years ago
October 10, 2016 – Cancer News Review
In this month's podcast, Johns Hopkins Kimmel Cancer Director William Nelson discusses drugs approved by the FDA including those that help cancer with the BRCA gene, the cost of breast cancer treatment and the financial burdens of cancer care and treatment.
Program Notes:
0:26 PARP inhibitors
1:27 Cancers that don’t have BRCA defects another drug helps
2:26 Are ones approved by FDA
2:40 Physical properties of cells and metastasis
3:41 inhibition might help
3:50 Costs of breast cancer treatment
4:51 More for trastuzumab
5:51 Ready to engage in life and what is the financial burden?
6:51 Value in care needed
7:15 Data on childhood cancer survival
8:32 End
Cancer News Review – Johns Hopkins Medicine Podcasts